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The goal of humankind is to alleviate the suffering from
disease and quest is to have good and robust health always.
The gain of knowledge through research is one of the primary
steps towards the same. With the newly emerging infectious
diseases, increase in the antimicrobial resistance and also
the increasing incidences of noncommunicable diseases have
thrown at us new challenges to develop better diagnostics,
drugs, medical devices, and vaccines.
The present century is the era of biotechnology and infor-
mation technology. Biotechnology has become the amal-
gamation of several technologies ranging from the field
of biomedical research and synthetic biology and further
transcending to engineering, nanotechnology, and bioinfor-
matics. Biomedicine have gone a step further converging
biology, chemistry, and physics which have led to increasing
the understanding of the pathophysiological processes by
deciphering the molecular interaction that plays a significant
role in the cellular mechanism and thus devising new strate-
gies to produce new diagnostics and therapies.
Health innovation process needs a boost to stem the
declining productivity and high turnover rates of drugs with
escalating cost. So, the promotion of newer technologies
and innovation is the need of the hour. It is imperative to
have health innovation reach the masses and add a value
to the public health system of nations across the globe.
With adequate impetus we are ushering in today the era
of knowledge driven, evidence-based innovation in fields of
biotechnology and biomedicine, leading to development of
platform technologies which can have global implications.
This special issue in the journal of Biomed Research is a
step towards the path which brings us to the forefront of new
innovations and technologies that transcend all aspects of
translational research and have high significance in the public
health arena. Hence the editors have selected the cutting edge
research in the field of medical biology which has bearing in
the future of science.
The paper by Y. Qin et al., which have found that
DNA vaccine encoding BCR/ABL-hil2 enhances the in vivo
humoral and cellular responses in BABL/c mice, hence
presenting a new targeted immunotherapy approach which
holds promising finding for patients with chronic myeloid
leukemia (CML). The paper postulates these findings and if
the research is translated to effective DNA vaccine in humans
for CML patients, it will help in the treatment of residual
disease after the treatment with chemotherapy or targeted
therapy.
New research in antimicrobial therapy has become a
very essential tool to fight infection in context of growing
antibiotic resistance. The paper by J. J. G.-R. Rodr´ıguez et
al., has given alternate strategy with cloned antimicrobial
peptide PaDef homologous to defensins from Mexican avo-
cado (Persea americana var. drymifolia). This paper reports
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the antimicrobial activity of defensin from avocado against
Escherichia coli and Staphylococcus aureus. The alternative
method of pathogen control paves the way for development
of new treatment regimes against infectious pathogens.
The effect of curcumin from Curcuma longa L. (from
the family Zingiberaceae) on fighting oxidative stress in liver
and brain in mice fed with excessive alcohol was studied
in the paper by C. W. Pyun et al. The finding showed that
curcumin increases brain and hepatic phosphatidylcholine
hydroperoxide levels in mice after consumption of excessive
alcohol, hence proving the effectiveness of consumption of
daily curcumin intake in protecting the liver and brain against
alcohol induced oxidative stress.
The G. C. Fontes et al., paper on characterization of
alginate and OSA starch bead for the use of controlled release
carrier for penicillin is an important finding to alleviate the
discomfort of patients undergoing conventional administra-
tion of the vital drug.This paper also has long implications on
designing public health intervention for delivery of essential
drugs.
The paper by M. P. L. Cunha et al., is the analysis of the
vaccine adverse event reporting in the state of Rondonia,
Brazil during the first ten years (1998–2008) after intro-
duction of vaccines for BCG (Bacillus Calmette-Guerin),
DTwP/Hib (hepatitis B, diphtheria, tetanus, pertussis +
hemophillus influenza b), DTP (diphtheria, tetanus, and
pertussis), MMR (measles, mumps, and rubella) and yellow
fever (YF) is amajor impact paper onpublic health.This study
is of paramount importance which can help the regulators
and clinicians alike from all over the world in gauzing the
effectiveness and adverse reaction that can be anticipated
from the regular vaccines that are a part of immunization
programs of many countries around the world.
The simple model to analyze assessment of the antitoxin
antibodies in the paper by A. Skvortsov and P. Gray also
is an essential scientific finding which was once validated
experimentally will be a very useful tool to assess in vitro
the potential of protective antibodies for further evaluation
in vivo.
The compilation of the articles in the special issue is
very good read of high impact research and important
scientific findings would have robust impact on strategizing
innovative solutions of public health interventions globally;
hence, all editors have selected the most promising research
for publication.
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